
The Competition Commission of India (CCI) has appealed in the Supreme Court against the Karnataka High Court’s interim stay on an investigation that the watchdog had ordered against e-commerce firms Amazon and Flipkart related to anti-competitive business practices, according to sources.
The Confederation of All India Traders (CAIT), which represents 70 million traders, termed the appeal in the Supreme Court against Amazon and Flipkart as “logical.”
“The appeal by CCI (in Supreme Court) is one of the most logical and most awaited steps to nail both Amazon and Flipkart for continuing their respective mal-practices including predatory pricing, deep discounting (and) exclusive arrangements with brands and holding inventory,” alleged Praveen Khandelwal, secretary-general of the CAIT, which has been leading a campaign against both Amazon and Walmart for more than two years.
Early this year, the CCI ordered an investigation against e-commerce players after the Delhi Vyapar Mahasangh, a traders’ body, filed a complaint against the firms’ practices like giving deep discounts on online sales of smartphones and cherry-picking sellers. In a major relief to e-commerce majors Amazon India and Flipkart, the Karnataka High Court had granted an interim stay on the CCI’s order. The court had granted the respondents eight weeks to file a counter.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas